GEHC vs BIIB — Key Metrics
| Metric | GEHC (GE HEALTHCARE TECHNOLOGIES INC) | BIIB (BIOGEN INC) |
|---|---|---|
| Price | 83.66 | 251.41 |
| Market Cap | 37.83 Billion | 37.16 Billion |
| P/E (TTM) | 17.65 | 106.53 |
| P/B (Quarterly) | 2.952 | 1.907 |
| P/S (TTM) | 1.75 | 3.61 |
| Net Profit Margin (TTM) | 10.0 | 3.4 |
| Gross Margin (TTM) | 39.9 | 74.0 |
| ROE (TTM) | 19.7 | 1.9 |
| Revenue Growth YoY (TTM) | n/a | n/a |
Upfront Investment - S&P 500 Stock Comparison & AI Analysis
AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.
Performance Comparison
AI Model Recommendation
Outperform
Greatly Outperform
Recommendation Summary
Stock GEHC is projected to outperform the market, stock BIIB is projected to greatly outperform the market. Upfront Recommendation: BIIB.
Financial Metrics
| GEHC | Metrics | BIIB |
|---|---|---|
| $83.66 | Price | $251.41 |
| — | Market Capitalization | — |
| 17.65 | Price to Earnings Ratio | 106.53 |
| 1.75 | Price to Sales | 3.61 |
| 20.02 | Price to FCF Ratio | 18.09 |
| 4.38 | Price to Gross Profit | 4.88 |
| 28.85 | Price to R&D | 17.27 |
| 3.29 | Price to Current Assets | 4.9 |
GEHC vs BIIB at a glance
GE Healthcare Technologies INC (GEHC) and Biogen INC (BIIB) are both in the Healthcare sector. They are similar in size: $37.8 billion and $37.2 billion in market value.
On trailing-twelve-month figures, GEHC trades at 17.6 times trailing earnings and BIIB at 106.5; net profit margins are 10.0% and 3.4%.
The Upfront Investment model currently rates GEHC Outperform and BIIB Greatly Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.